Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1075 studies found for:    Huntington's Disease
Show Display Options
Rank Status Study
1 Withdrawn Characterization of the Profile of Dysarthria in Huntington's Disease, Using the Clinical Evaluation Battery of Dysarthria
Conditions: Dysarthria;   Huntington Disease
Intervention: Other: Study of dysarthria in patients with Huntington's disease
2 Completed A Study of the Novel Drug Dimebon in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Other: Placebo;   Drug: Dimebon
3 Unknown  Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN)
Condition: Huntington Disease
Intervention:
4 Active, not recruiting Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
Condition: Huntington Disease
Intervention: Drug: pridopidine
5 Completed A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Versus Placebo for Symptomatic Treatment in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: Pridopidine;   Other: Placebo
6 Completed A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease
Condition: Huntington's Disease
Intervention: Drug: SEN0014196
7 Completed An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196
Condition: Huntington Disease
Interventions: Drug: SEN0014196 (Low Dose);   Drug: SEN0014196 (High Dose);   Drug: Placebo
8 Terminated Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea
Conditions: Huntington's Disease;   Chorea
Interventions: Drug: AFQ056;   Drug: Placebo
9 Recruiting Study of Biomarkers That Predict the Evolution of Huntington's Disease
Condition: Huntington Disease
Interventions: Other: Huntington patient evaluation;   Other: Healthy subject evaluation
10 Completed Family Health After Predictive Huntington Disease (HD) Testing
Condition: Huntington Disease
Intervention: Genetic: Mutation in the gene
11 Completed Caregiver Burden in Huntington's Disease
Condition: Caregiver of Huntington's Disease Patient
Intervention: Other: ZARIT Burden Interview
12 Recruiting Exercise Effects in Huntington's Disease
Condition: Huntington's Disease
Intervention: Behavioral: Exercise training
13 Completed Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease
Condition: Huntington's Disease
Intervention: Drug: Dimebon
14 Completed A Study of Treatment With Pridopidine (ACR16) in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: ACR16;   Drug: Placebo
15 Completed A Study of Pridopidine (ACR16) for the Treatment of Patients With Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: ACR16 10 mg;   Drug: ACR16 22.5 mg;   Drug: ACR16 45 mg;   Other: Placebo
16 Not yet recruiting PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease
Condition: Huntington's Disease
Intervention: Device: Deep Brain Stimulation
17 Active, not recruiting Neurobiological Predictors of Huntington's Disease (PREDICT-HD)
Condition: Huntington Disease
Intervention:
18 Completed Neuroprotection by Cannabinoids in Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD);   Drug: Placebo
19 Completed
Has Results
Pilot Study of Minocycline in Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: minocycline;   Drug: Matching placebo
20 Completed TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
Condition: Huntington Disease
Intervention: Drug: Ethyl-EPA (Miraxion™)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.